Of additional related interest, a recent study reported induction of CXCL16 in bone stroma conditioned by prostate cancer cells, and elevated serum levels of CXCL16 in patients with metastatic prostate cancer [50]. The gene discussed is CXCL16; the disease is metastatic prostate carcinoma.